Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mass Balance of [14C]ET-26 in Healthy Chinese Men
NCT06822114Phase 1Completed
- Sponsor
- Jinzhou Ahon Pharmaceutical Co., Ltd.
- Start
- Jul 2023
- Primary completion
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of methoxyethyl etomidate in general anesthesia, sponsored by Jinzhou Ahon Pharmaceutical Co., Ltd. Primary endpoint: Pharmacokinetic parameters up to 168 hours. Started Jul 2023; status: completed.
02
Drugs
methoxyethyl etomidate
03
Conditions
general anesthesia
Beyond the preview
Go deeper on NCT06822114.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06822114.